[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-335885-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-335885-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","a-comprehensive-pan-cancer-analysis-of-prognostic-value-and-potential-clinical-implications-of-fth1-in-cancer-immunotherapy-research-report","A comprehensive pan-cancer analysis of prognostic value and potential clinical implications of FTH1 in cancer immunotherapy - Research report","","Pan-cancer immunotherapy remains limited by incomplete understanding of biomarker-driven immune regulation, particularly the roles of the heavy chain of ferritin (FTH1). This study systematically assesses FTH1’s prognostic value and immune functions across solid tumors. Bioinformatics and multiple algorithms characterize immune mechanisms within the tumor immune microenvironment, while single-cell sequencing and multiplex immunofluorescence evaluate FTH1 co-expression in tumor and immune cells. Results link aberrant FTH1 expression to immunotherapy resistance, tumor immune checkpoint activity, and immune pathway signatures.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/a-comprehensive-pan-cancer-analysis-of-prognostic-value-and-potential-clinical-implications-of-fth1-in-cancer-immunotherapy-research-report/335885/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/a-comprehensive-pan-cancer-analysis-of-prognostic-value-and-potential-clinical-implications-of-fth1-in-cancer-immunotherapy-research-report/335885.png","ImageObject",300,407,{"name":42,"@type":43},"Logic","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main research purpose regarding FTH1 in immunotherapy?","Question",{"text":63,"@type":64},"To systematically evaluate the prognostic significance and immune role of FTH1 in pan-cancer immunotherapy, clarifying how it may affect outcomes and treatment response.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How is FTH1 studied within the tumor immune microenvironment?",{"text":68,"@type":64},"The immune landscape and mechanisms of FTH1 in the TIME are analyzed using multiple algorithms and bioinformatics methods, with single-cell sequencing and multiplex immunofluorescence to assess FTH1 co-expression in tumor and immune cells.",{"name":70,"@type":61,"acceptedAnswer":71},"What relationship does the study find between FTH1 expression and immunotherapy response?",{"text":72,"@type":64},"Aberrant FTH1 expression patterns correlate with immunotherapy resistance, and patients with higher FTH1 expression tend to benefit less from immunotherapies.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},335885,1790179708,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},1099513958762,"https://ap-avatar.wpscdn.com/avatar/1000023916a998db790?x-image-process=image/resize,m_fixed,w_180,h_180&k=1784791008015729253","Cancer Immunology, Immunotherapy (2024) 73:37 [https://doi.org/10.1007/s00262-023-03625-x](https://doi.org/10.1007/s00262-023-03625-x)  \nA comprehensive pan‑cancer analysis of prognostic value  \nand potential clinical implications of FTH1 in cancer immunotherapy  \nYuejun Luo1,2 · Chengming Liu1,2 · Yuxin Yao1,2 · Xiaoya Tang1,2 · Enzhi Yin1,2 · Zhiliang Lu1 · Nan Sun1,2 · Jie He1,2  \nReceived: 19 November 2023 / Accepted: 27 December 2023 / Published online: 28 January 2024 © The Author(s) 2024  \nAbstract  \nBackground Numerous studies have highlighted the crucial value of the heavy chain of ferritin (FTH1) as a key regulator of iron metabolism and a suppressor of ferroptosis, intimately tied to the tumor immune microenvironment (TIME) . Nevertheless, the precise impact of FTH1 on cancer immunotherapy remains vague. Our study aims to systematically explore the prognostic significance and immune role of FTH1 in pan-cancers immunotherapy.  \nMethods Our study delves into the potential of FTH1 as an immunotherapeutic target within the TIME of various solid cancers. The immune landscape and underlying mechanisms ofFTH1 in the TIME were investigated by multiple algorithmsand bioinformatics methods. Single-cell sequencing analysis and multiplex immunofluorescence staining techniques are applied to observe FTH1 co-expression on both tumor and immune cells.  \nResults FTH1 exhibited aberrant expression patterns across multiple cancers, which is strongly correlated with immunotherapy resistance. Patients with high FTH1 expression levels tended to derive less benefit from immunotherapies. Moreover, FTH1 demonstrated a significant correlation with TIME infiltration, immune checkpoint molecules, and immune-related pathways. Notably, FTH1 showed a positive association with macrophage infiltrations, its expression was particularly noteworthy in malignant cells and macrophages. Inhibiting FTH1-related signaling pathways appeared to be a potential strategy to counteract tumor immunotherapy resistance.  \nConclusion Our comprehensive analyses may offer valuable insights into the role of FTH1 in tumor immunotherapy. The observed correlations pave the way for further functional experiments, fostering an enhanced understanding that could shape future research endeavors.  \nKeywords FTH1 · Immunotherapy · Single-cell · Macrophage · And TIME  \nAbbreviations  \nCCLE Cancer cell line encyclopedia  \nCR Complete response  \nDFS Disease-free survival  \nDSS Disease specific survival  \n* Nan Sun [sunnan@cicams.ac.cn](sunnan@cicams.ac.cn)  \n* Jie He [prof.jiehe@gmail.com](prof.jiehe@gmail.com)  \n1 Department of Thoracic Surgery, National Cancer Center/ National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China  \n2 State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China  \nGEO  \nFTH1  \nHPC-like  \nKEGG  \nMSI  \nOS  \nPD  \nPPI  \nPR  \nRFS  \nSD  \nTCGA  \nTECs  \nTIDE  \nTIME  \nTMAs  \nTMB  \nGene expression omnibus Heavy chain of ferritin Hepatic progenitor cells  \nKyoto encyclopedia of genes and genomes Microsatellite instability  \nOverall survival Progressive disease Protein–protein interaction Partial response Progression-free survival Stable disease  \nThe cancer genome atlas  \nTumor-associated endothelial cells Tumor immune dysfunction and exclusion Tumor immune microenvironment Tissue microarrays  \nTumor mutation burden  \nFig. 1 Expression landscape of FTH1 in the normal and tumor tissues. A FTH1 expression levels in tumor cell lines from the CCLE dataset. BFTH1 expression in the normal and tumor samples analyzed by TCGA dataset  \nIntroduction  \nOver the past decades, our understanding of cell death has expanded with the identification of various pathways, encompassing both accidental and regulated mechanisms [1–3]. Among ","cbCaiv5p8OGGM4Am","https://ap.wps.com/l/cbCaiv5p8OGGM4Am","pdf",7648375,13,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Ferroptosis and tumor immune response\n## Ferritin heavy chain (FTH1) and iron metabolism\n# Study scope\n## Table 1: Cancer types included","[{\"question\":\"What is the main research purpose regarding FTH1 in immunotherapy?\",\"answer\":\"To systematically evaluate the prognostic significance and immune role of FTH1 in pan-cancer immunotherapy, clarifying how it may affect outcomes and treatment response.\"},{\"question\":\"How is FTH1 studied within the tumor immune microenvironment?\",\"answer\":\"The immune landscape and mechanisms of FTH1 in the TIME are analyzed using multiple algorithms and bioinformatics methods, with single-cell sequencing and multiplex immunofluorescence to assess FTH1 co-expression in tumor and immune cells.\"},{\"question\":\"What relationship does the study find between FTH1 expression and immunotherapy response?\",\"answer\":\"Aberrant FTH1 expression patterns correlate with immunotherapy resistance, and patients with higher FTH1 expression tend to benefit less from immunotherapies.\"}]","A comprehensive pan-cancer analysis of prognostic value and potential clinical implications of FTH1 in cancer immunotherapy - Research report | PDF",1790012722,33]